Immune Checkpoint Inhibitors and Mismatch Repair Status in Advanced Endometrial Cancer: Elective Affinities

Since endometrial cancers (ECs) are frequently TMB-H and MSI-H/dMMR tumors, this element has provided the rationale for testing immune checkpoint inhibitors (ICIs), which have recently emerged as a potential game-changer. However, several questions remain to be addressed, including the identificatio...

Descripción completa

Detalles Bibliográficos
Autor principal: Rizzo, Alessandro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Perspective
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9267485/
https://www.ncbi.nlm.nih.gov/pubmed/35807197
http://dx.doi.org/10.3390/jcm11133912

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9267485/
https://www.ncbi.nlm.nih.gov/pubmed/35807197
http://dx.doi.org/10.3390/jcm11133912

Ejemplares similares